中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基于女性偏倚现象探讨性激素调控T淋巴细胞介导自身免疫性肝炎的作用机制

王海强 孙大沙 王晗 田家华 崔馨月 李明

引用本文:
Citation:

基于女性偏倚现象探讨性激素调控T淋巴细胞介导自身免疫性肝炎的作用机制

DOI: 10.12449/JCH250421
基金项目: 

国家中医药管理局第五批全国中医临床优秀人才研修项目(国中医药人教函〔2022〕1号) ;

黑龙江省中医药科研基金项目 (ZHY2023-125)

利益冲突声明:本文不存在任何利益冲突。
作者贡献声明:王海强、孙大沙负责文章的构思与设计,论文撰写;王晗、田家华负责论文修订;崔馨月负责论文修订与审校;李明负责最终版本修订。
详细信息
    通信作者:

    李明, harbinxin@163.com (ORCID: 0009-0000-7315-464X)

Mechanism of action of sex hormones in regulating T cell-mediated autoimmune hepatitis: A study based on the phenomenon of female bias

Research funding: 

The Fifth Batch of National TCM Clinical Excellent Talents Training Project of the State Administration of Traditional Chinese Medicine (The Teaching Letter of Chinese Medicine [2022] No.1) ;

Heilongjiang Province Traditional Chinese Medicine Research Fund Project (ZHY2023-125)

More Information
    Corresponding author: LI Ming, harbinxin@163.com (ORCID: 0009-0000-7315-464X)
  • 摘要: 自身免疫性肝炎(AIH)是一种以肝实质破坏和慢性纤维化为特征的自身免疫性疾病,常由T淋巴细胞介导发生。AIH的发病机制涉及多个因素,包括性别、地域、环境因素以及遗传易感性等。在AIH中,常出现女性偏倚现象,即女性发病风险远高于男性,这种性别差异与多种因素相关,性激素可能是导致AIH女性偏向性的重要因素之一,然而机制尚不完全清楚。深入了解性激素在AIH发病中的作用机制将有助于更好理解该病的发病机理,并可能为未来的治疗方法及预防策略的开发提供重要线索。本文综述雌激素和雄激素通过调控T淋巴细胞调节AIH发病的作用机制,以期为深入探讨性激素在AIH病因学中的潜在作用提供新思路和新方向。

     

  • 注: AR,雄激素受体;ERα,雌激素受体α;ERβ,雌激素受体β;NO,一氧化氮;COX2,环氧合酶-2;PPAR-α,过氧化物酶体增殖物激活受体-α;Foxp3,叉状头/翅膀状螺旋转录因子3;AHR,芳香烃受体;AHRR,AHR抑制因子;ARNT,AHR核易位子;SFGL2,纤维蛋白原样蛋白2;Th,辅助性T淋巴细胞;Treg,调节性T淋巴细胞。

    图  1  性激素调控T淋巴细胞在AIH中的作用机制

    Figure  1.  The mechanism of sex hormones regulating T lymphocytes in AIH

  • [1] MURATORI L, LOHSE AW, LENZI M. Diagnosis and management of autoimmune hepatitis[J]. BMJ, 2023, 380: e070201. DOI: 10.1136/bmj-2022-070201.
    [2] HAN B, TU CT. Diagnosis and management of autoimmune hepatitis in specific clinical phenotypes and patient populations: Current concepts[J/CD]. Chin J Liver Dis(Electronic Version), 2023, 15( 4): 16- 21.

    韩冰, 涂传涛. 特殊临床表型及特殊人群自身免疫性肝炎诊治现状[J/CD]. 中国肝脏病杂志(电子版), 2023, 15( 4): 16- 21.
    [3] FORSYTH KS, JIWRAJKA N, LOVELL CD, et al. The conneXion between sex and immune responses[J]. Nat Rev Immunol, 2024, 24( 7): 487- 502. DOI: 10.1038/s41577-024-00996-9.
    [4] MA X, WANG Q, XIAO X, et al. Guidelines on the diagnosis and management of autoimmune hepatitis(2021)[J]. J Clin Hepatol, 2022, 38( 1): 42- 49. DOI: 10.3760/cma.j.cn112138-20211112-00796.

    马雄, 王绮夏, 肖潇, 等. 自身免疫性肝炎诊断和治疗指南(2021)[J]. 临床肝胆病杂志, 2022, 38( 1): 42- 49. DOI: 10.3760/cma.j.cn112138-20211112-00796.
    [5] LAMBA M, NGU JH, STEDMAN CAM. Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis[J]. Clin Gastroenterol Hepatol, 2021, 19( 3): 573- 579. e 1. DOI: 10.1016/j.cgh.2020.05.061.
    [6] TRIVEDI PJ, HIRSCHFIELD GM. Recent advances in clinical practice: Epidemiology of autoimmune liver diseases[J]. Gut, 2021, 70( 10): 1989- 2003. DOI: 10.1136/gutjnl-2020-322362.
    [7] TRIVEDI PJ, HIRSCHFIELD GM, ADAMS DH, et al. Immunopathogenesis of primary biliary cholangitis, primary sclerosing cholangitis and autoimmune hepatitis: Themes and concepts[J]. Gastroenterology, 2024, 166( 6): 995- 1019. DOI: 10.1053/j.gastro.2024.01.049.
    [8] COLAPIETRO F, MAISONNEUVE P, LYTVYAK E, et al. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis[J]. J Hepatol, 2024, 80( 1): 53- 61. DOI: 10.1016/j.jhep.2023.09.010.
    [9] LIBERT C, DEJAGER L, PINHEIRO I. The X chromosome in immune functions: When a chromosome makes the difference[J]. Nat Rev Immunol, 2010, 10( 8): 594- 604. DOI: 10.1038/nri2815.
    [10] HEYMANN F, TACKE F. Immunology in the liver: From homeostasis to disease[J]. Nat Rev Gastroenterol Hepatol, 2016, 13( 2): 88- 110. DOI: 10.1038/nrgastro.2015.200.
    [11] VUERICH M, WANG N, KALBASI A, et al. Dysfunctional immune regulation in autoimmune hepatitis: From pathogenesis to novel therapies[J]. Front Immunol, 2021, 12: 746436. DOI: 10.3389/fimmu.2021.746436.
    [12] STARK JM, TIBBITT CA, COQUET JM. The metabolic requirements of Th2 cell differentiation[J]. Front Immunol, 2019, 10: 2318. DOI: 10.3389/fimmu.2019.02318.
    [13] CHEN HR, HAN ZY, FAN YY, et al. CD4+ T-cell subsets in autoimmune hepatitis: A review[J]. Hepatol Commun, 2023, 7( 10): e0269. DOI: 10.1097/HC9.0000000000000269.
    [14] HENEGHAN MA, YEOMAN AD, VERMA S, et al. Autoimmune hepatitis[J]. Lancet, 2013, 382( 9902): 1433- 1444. DOI: 10.1016/S0140-6736(12)62163-1.
    [15] TAUBERT R, HARDTKE-WOLENSKI M, NOYAN F, et al. Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies[J]. J Hepatol, 2014, 61( 5): 1106- 1114. DOI: 10.1016/j.jhep.2014.05.034.
    [16] BEHFARJAM F, SANATI MH, NASSERI MOGHADDAM S, et al. Role of Th1/Th2 cells and related cytokines in autoimmune hepatitis[J]. Turk J Gastroenterol, 2017, 28( 2): 110- 114. DOI: 10.5152/tjg.2017.17501.
    [17] AKKOÇ T. Re: The role of Th1/Th2 cells and associated cytokines in autoimmune hepatitis[J]. Turk J Gastroenterol, 2017, 28( 2): 115- 116. DOI: 10.5152/tjg.2017.14021.
    [18] ZHU JX, CHEN HX, CUI JJ, et al. Oroxylin A inhibited autoimmune hepatitis-induced liver injury and shifted Treg/Th17 balance to Treg differentiation[J]. Exp Anim, 2023, 72( 3): 367- 378. DOI: 10.1538/expanim.22-0171.
    [19] SONG JG, DAI J, CHEN XP, et al. Bifidobacterium mitigates autoimmune hepatitis by regulating IL-33-induced Treg/Th17 imbalance via the TLR2/4 signaling pathway[J]. Histol Histopathol, 2024, 39( 5): 623- 632. DOI: 10.14670/HH-18-669.
    [20] JI WW, PENG X, LOU TL, et al. Total flavonoids from Tetrastigma hemsleyanum ameliorates inflammatory stress in concanavalin A-induced autoimmune hepatitis mice by regulating Treg/Th17 immune homeostasis[J]. Inflammopharmacology, 2019, 27( 6): 1297- 1307. DOI: 10.1007/s10787-019-00599-0.
    [21] MA L, ZHANG LW, ZHUANG Y, et al. The imbalance between Foxp3+Tregs and Th1/Th17/Th22 cells in patients with newly diagnosed autoimmune hepatitis[J]. J Immunol Res, 2018, 2018: 3753081. DOI: 10.1155/2018/3753081.
    [22] AI G, YAN WM, YU HJ, et al. Soluble Fgl2 restricts autoimmune hepatitis progression via suppressing Tc17 and conventional CD8+ T cell function[J]. J Gene Med, 2018, 20( 7-8): e3023. DOI: 10.1002/jgm.3023.
    [23] MOULTON VR. Sex hormones in acquired immunity and autoimmune disease[J]. Front Immunol, 2018, 9: 2279. DOI: 10.3389/fimmu.2018.02279.
    [24] XING EZ, BILLI AC, GUDJONSSON JE. Sex bias and autoimmune diseases[J]. J Invest Dermatol, 2022, 142( 3 Pt B): 857- 866. DOI: 10.1016/j.jid.2021.06.008.
    [25] BROWN MA, SU MA. An inconvenient variable: Sex hormones and their impact on T cell responses[J]. J Immunol, 2019, 202( 7): 1927- 1933. DOI: 10.4049/jimmunol.1801403.
    [26] CHAKRABORTY B, BYEMERWA J, KREBS T, et al. Estrogen receptor signaling in the immune system[J]. Endocr Rev, 2023, 44( 1): 117- 141. DOI: 10.1210/endrev/bnac017.
    [27] THOMAS P, PANG Y, FILARDO EJ, et al. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells[J]. Endocrinology, 2005, 146( 2): 624- 632. DOI: 10.1210/en.2004-1064.
    [28] SINGH RP, HAHN BH, BISCHOFF DS. Interferon genes are influenced by 17β-estradiol in SLE[J]. Front Immunol, 2021, 12: 725325. DOI: 10.3389/fimmu.2021.725325.
    [29] ADURTHI S, KUMAR MM, VINODKUMAR HS, et al. Oestrogen Receptor-α binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer[J]. Sci Rep, 2017, 7( 1): 17289. DOI: 10.1038/s41598-017-17102-w.
    [30] MOHAMMAD I, STARSKAIA I, NAGY T, et al. Estrogen receptor α contributes to T cell-mediated autoimmune inflammation by promoting T cell activation and proliferation[J]. Sci Signal, 2018, 11( 526): eaap9415. DOI: 10.1126/scisignal.aap9415.
    [31] McNEER SK, KOCINSKI AD, GOODMAN WA. Murine CD4+ T cells exhibit sexually dimorphic responses to estrogen signaling[J]. J Immunol, 2023, 210( 1_Supplement): 64. 13. DOI: 10.4049/jimmunol.210.supp.64.13.
    [32] GOODMAN WA, BEDOYAN SM, HAVRAN HL, et al. Impaired estrogen signaling underlies regulatory T cell loss-of-function in the chronically inflamed intestine[J]. Proc Natl Acad Sci USA, 2020, 117( 29): 17166- 17176. DOI: 10.1073/pnas.2002266117.
    [33] MCMURRAY RW, SUWANNAROJ S, NDEBELE K, et al. Differential effects of sex steroids on T and B cells: Modulation of cell cycle phase distribution, apoptosis and bcl-2 protein levels[J]. Pathobiology, 2001, 69( 1): 44- 58. DOI: 10.1159/000048757.
    [34] KWON H, SCHAFER JM, SONG NJ, et al. Androgen conspires with the CD8+ T cell exhaustion program and contributes to sex bias in cancer[J]. Sci Immunol, 2022, 7( 73): eabq2630. DOI: 10.1126/sciimmunol.abq2630.
    [35] HOFFMANN JP, LIU JA, SEDDU K, et al. Sex hormone signaling and regulation of immune function[J]. Immunity, 2023, 56( 11): 2472- 2491. DOI: 10.1016/j.immuni.2023.10.008.
    [36] WALECKI M, EISEL F, KLUG J, et al. Androgen receptor modulates Foxp3 expression in CD4+CD25+Foxp3+ regulatory T-cells[J]. Mol Biol Cell, 2015, 26( 15): 2845- 2857. DOI: 10.1091/mbc.E14-08-1323.
    [37] ZHU ML, BAKHRU P, CONLEY B, et al. Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator[J]. Nat Commun, 2016, 7: 11350. DOI: 10.1038/ncomms11350.
    [38] LYU TT. Diethylstilbestrol inhibits acute autoimmune hepatitis induced by concanavalin A in mice[D]. Guangzhou: Southern Medical University, 2013.

    吕廷廷. 己烯雌酚抑制刀豆蛋白A诱导的小鼠急性自身免疫性肝炎[D]. 广州: 南方医科大学, 2013.
    [39] ZHANG YW, WANG L, QIU SL, et al. Effect of high concentration estradiol on acute autoimmune hepatitis induced by ConA[J]. J Sun Yat Sen Univ Med Sci, 2021, 42( 2): 185- 192. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2021.0025.

    张译文, 汪黎, 邱素苈, 等. 高浓度雌二醇对刀豆蛋白A诱导小鼠急性自身免疫性肝炎的影响[J]. 中山大学学报(医学科学版), 2021, 42( 2): 185- 192. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2021.0025.
    [40] LIBERAL R, GRANT CR, MA Y, et al. CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease[J]. J Autoimmun, 2016, 72: 102- 112. DOI: 10.1016/j.jaut.2016.05.005.
    [41] VUERICH M, HARSHE R, FRANK LA, et al. Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis[J]. J Hepatol, 2021, 74( 1): 48- 57. DOI: 10.1016/j.jhep.2020.06.044.
    [42] GUAN XN, POLESSO F, WANG CJ, et al. Androgen receptor activity in T cells limits checkpoint blockade efficacy[J]. Nature, 2022, 606( 7915): 791- 796. DOI: 10.1038/s41586-022-04522-6.
    [43] ZHANG MA, AHN JJ, ZHAO FL, et al. Antagonizing peroxisome proliferator-activated receptor α activity selectively enhances Th1 immunity in male mice[J]. J Immunol, 2015, 195( 11): 5189- 5202. DOI: 10.4049/jimmunol.1500449.
    [44] BEN-BATALLA I, VARGAS-DELGADO ME, von AMSBERG G, et al. Influence of androgens on immunity to self and foreign: Effects on immunity and cancer[J]. Front Immunol, 2020, 11: 1184. DOI: 10.3389/fimmu.2020.01184.
    [45] MARTINELLI S, NANNINI G, CIANCHI F, et al. The impact of microbiota-immunity-hormone interactions on autoimmune diseases and infection[J]. Biomedicines, 2024, 12( 3): 616. DOI: 10.3390/biomedicines12030616.
    [46] SUN C, ZHU DZ, ZHU Q, et al. The significance of gut microbiota in the etiology of autoimmune hepatitis: A narrative review[J]. Front Cell Infect Microbiol, 2024, 14: 1337223. DOI: 10.3389/fcimb.2024.1337223.
    [47] CHENG ZL, YANG L, CHU HK. The gut microbiota: A novel player in autoimmune hepatitis[J]. Front Cell Infect Microbiol, 2022, 12: 947382. DOI: 10.3389/fcimb.2022.947382.
  • 加载中
图(1)
计量
  • 文章访问数:  125
  • HTML全文浏览量:  33
  • PDF下载量:  9
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-07-24
  • 录用日期:  2024-09-04
  • 出版日期:  2025-04-25
  • 分享
  • 用微信扫码二维码

    分享至好友和朋友圈

目录

    /

    返回文章
    返回